adagrasib
mirati
['lcsm,(-blcsm)', 'krystal-1', 'sclc', 'nsclc', 'adagrasib']
krystal-1: #adagrasib in kras g12c mutant nsclc presented by dr. n=116
orr=43% (dor: 8.5 months)
median pfs=6.5 months (95% ci: 4.7-8.4)
median os=12.6 months (95% ci: 9.2-19.2) a great targeted therapy option for kras g12c mutant nsclc #asco22 #lcsm 
Oncologist taking care of people with cancer at Georgetown University | Father/husband/immigrant | #SoMeEditor @ClinicalLung | #LCSM